U.S. market Open. Closes in 3 hours 46 minutes

MDNA | Medicenna Therapeutics Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses16.30M22.47M17.39M8.24M4.73M7.42M7.70M1.20MN/A
Selling, General & Admin6.99M7.72M6.49M2.49M2.21M3.00M4.02M469.71KN/A
Research & Development9.30M14.72M10.87M5.87M3.02M5.09M4.23M771.41KN/A
Other Operating Expenses5.00K37.00K40.00K-117.48K-499.37K-661.94K-547.40K-41.45KN/A
Operating Income-21.64M-22.30M-17.19M-8.21M-4.73M-7.42M-7.70M-1.20MN/A
Other Expenses / Income11.60M-277.00K-102.00K-71.27K19.15K-40.62K66.87K-134.40KN/A
Before Tax Income-10.05M-22.58M-17.29M-8.28M-4.71M-7.47M-7.63M-1.33MN/A
Income Tax Expenses-11.60M69.00K-106.00K32.27K19.25KN/AN/AN/AN/A
Net Income1.55M-22.65M-17.18M-8.31M-4.71M-7.47M-7.63M-1.33MN/A
Interest Expenses-11.60M69.00KN/AN/AN/AN/A60.00441.00N/A
Basic Shares Outstanding64.74M54.29M49.66M31.90M25.67M24.58M16.91M16.00M190.41K
Diluted Shares Outstanding64.74M54.29M49.66M31.90M25.67M24.58M16.91M16.00M190.41K
EBITDA-21.64M-22.26M-17.15M-8.20M-4.74M-7.46M-7.66M-1.20MN/A
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-21.64M-22.51M-17.29M-8.28M-4.69M-7.47M-7.63M-1.33MN/A
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙